Similar articles

• Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease.

  Rodriguez AE, Fernandez-Pereira C, Mieres J. Rodriguez AE, et al. JAMA Intern Med. 2014 Jun;174(6):1007. doi: 10.1001/jamainternmed.2014.776. JAMA Intern Med. 2014. PMID: 24887763 No abstract available.
• Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease.

  Takagi H, Umemoto T; ALICE Group. Takagi H, et al. JAMA Intern Med. 2014 Jun;174(6):1006-7. doi: 10.1001/jamainternmed.2014.773. JAMA Intern Med. 2014. PMID: 24887761 No abstract available.
• Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease--reply.

  Sipahi I. Sipahi I. JAMA Intern Med. 2014 Jun;174(6):1007-8. doi: 10.1001/jamainternmed.2014.762. JAMA Intern Med. 2014. PMID: 24887764 No abstract available.
• Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.

  Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C. Sipahi I, et al. JAMA Intern Med. 2014 Feb 1;174(2):223-30. doi: 10.1001/jamainternmed.2013.12844. JAMA Intern Med. 2014. PMID: 24296767 Review.
• Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: an updated meta-analysis of 4 randomized, controlled trials.

  Benedetto U, Ng C, Smith R, Raja SG; Cardiac Outcomes Meta-Analysis (COMET) Group. Benedetto U, et al. J Thorac Cardiovasc Surg. 2014 Nov;148(5):2430-2. doi: 10.1016/j.jtcvs.2014.08.028. Epub 2014 Aug 19. J Thorac Cardiovasc Surg. 2014. PMID: 25224547 Review. No abstract available.